3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
28
Other neoplasm
1
Gastrointestinal
1
Breast
1
Conditions
Precancerous Conditions
138
Lymphoma
35
Leukemia
34
Multiple Myeloma
33
Leukemia, Lymphocytic, Chronic, B-Cell
32
Neoplasms, Plasma Cell
31
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Monoclonal Gammopathy of Undetermined Significance
29
Lymphoma, Non-Hodgkin
29
Lymphoma, Mantle-Cell
29
Lymphoma, Large-Cell, Immunoblastic
29
Lymphoma, Large B-Cell, Diffuse
29
Lymphoma, Follicular
29
Burkitt Lymphoma
28
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
27
Lymphoma, B-Cell, Marginal Zone
27
Hodgkin Disease
27
Myelodysplastic Syndromes
26
Immunoglobulin Light-chain Amyloidosis
26
Myeloproliferative Disorders
25
Lymphoma, T-Cell, Cutaneous
25
Immunoblastic Lymphadenopathy
25
Waldenstrom Macroglobulinemia
24
Lymphoma, Large-Cell, Anaplastic
24
Leukemia, Myeloid, Acute
24
Uterine Cervical Neoplasms
22
Primary Myelofibrosis
22
Leukemia, Large Granular Lymphocytic
22
Leukemia, Hairy Cell
22
Thrombocythemia, Essential
21
Interventions
Control Groups
1
Capacity Building
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Cervical Cancer Screening
×
Other neoplasm
×
Clear all
NCT06800664
2025-01-31
HOPE-inG
Baylor University
Phase NA
Not yet recruiting
1,500 enrolled